PAR PHARMACEUTICAL COMPANIES, INC.

Inactive Instrument

Par Pharmaceutical Companies, Inc. Stock

Stocks

US69888P1066

Pharmaceuticals

End-of-day quote NYSE Other stock markets
- ^USD	-

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

on all subscriptions*

Enjoy this offer

* See conditions under "Our services"

Latest news : Par Pharmaceutical Companies, Inc.

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

Press Releases: Par Pharmaceutical Companies, Inc.

13-01-18	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Lamictal® XR	PU
13-01-02	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets	PU
12-12-05	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Atacand HCT®	PU
12-11-30	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Symbyax®	PU
12-10-29	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.	PU

More press releases

News in other languages: Par Pharmaceutical Companies, Inc.

15-05-18	Endo rachète Par Parma pour créer un géant des génériques
15-05-18	Altera : Wall Street débute la semaine sans tendance
15-05-18	Wall Street débute la semaine sans tendance
15-05-18	Accenture : Les valeurs à suivre sur les marchés américains
15-05-18	Endo : rachète le génériqueur Par Pharmaceuticals

Managers and Directors: Par Pharmaceutical Companies, Inc.

Manager	Title	Age	Since
Paul Campanelli CEO	Chief Executive Officer	64	2012-08-31

Director	Title	Age	Since
Paul Campanelli BRD	Director/Board Member	64	2012-08-31

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.24%	+1.71%	+10.73%	+82.15%	46.28B
	OTSUKA HOLDINGS CO., LTD.	+2.46%	+5.97%	+51.91%	+96.77%	34.73B
	CIPLA LIMITED	+0.35%	-2.01%	-9.52%	+34.04%	11.56B
	ZYDUS LIFESCIENCES LIMITED	+1.22%	-2.85%	+12.12%	+93.88%	11.32B
	KRKA, D. D.	+0.66%	+3.33%	+39.31%	+130.57%	9.27B
	GEDEON RICHTER	0.00%	+1.20%	+13.26%	+41.20%	7.13B
	ONO PHARMACEUTICAL CO., LTD.	+1.22%	+1.77%	+44.21%	-17.25%	6.6B
	GLENMARK PHARMACEUTICALS LIMITED	+0.81%	+0.44%	+29.73%	+236.35%	6.39B
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.63%	-3.58%	-37.81%	-7.82%	4.98B
	Average	+0.69%	+0.02%	+17.10%	+76.65%	15.36B
	Weighted average by Cap.	+0.94%	+1.07%	+22.27%	+83.04%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!